Literature DB >> 18632620

Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells.

Rebecca A Whipple1, Eric M Balzer, Edward H Cho, Michael A Matrone, Jennifer R Yoon, Stuart S Martin.   

Abstract

Solid tumor metastasis often involves detachment of epithelial carcinoma cells into the vasculature or lymphatics. However, most studies of cytoskeletal rearrangement in solid tumors focus on attached cells. In this study, we report for the first time that human breast tumor cells produce unique tubulin-based protrusions when detached from extracellular matrix. Tumor cell lines of high metastatic potential show significantly increased extension and frequency of microtubule protrusions, which we have termed tubulin microtentacles. Our previous studies in nontumorigenic mammary epithelial cells showed that such detachment-induced microtentacles are enriched in detyrosinated alpha-tubulin. However, amounts of detyrosinated tubulin were similar in breast tumor cell lines despite varying microtentacle levels. Because detyrosinated alpha-tubulin associates strongly with intermediate filament proteins, we examined the contribution of cytokeratin and vimentin filaments to tumor cell microtentacles. Increased microtentacle frequency and extension correlated strongly with loss of cytokeratin expression and up-regulation of vimentin, as is often observed during tumor progression. Moreover, vimentin filaments coaligned with microtentacles, whereas cytokeratin did not. Disruption of vimentin with PP1/PP2A-specific inhibitors significantly reduced microtentacles and inhibited cell reattachment to extracellular matrix. Furthermore, expression of a dominant-negative vimentin mutant disrupted endogenous vimentin filaments and significantly reduced microtentacles, providing specific genetic evidence that vimentin supports microtentacles. Our results define a novel model in which coordination of vimentin and detyrosinated microtubules provides structural support for the extensive microtentacles observed in detached tumor cells and a possible mechanism to promote successful metastatic spread.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632620      PMCID: PMC2859318          DOI: 10.1158/0008-5472.CAN-07-6589

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  A monomeric red fluorescent protein.

Authors:  Robert E Campbell; Oded Tour; Amy E Palmer; Paul A Steinbach; Geoffrey S Baird; David A Zacharias; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

2.  Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments.

Authors:  John E Eriksson; Tao He; Amy V Trejo-Skalli; Ann-Sofi Härmälä-Braskén; Jukka Hellman; Ying-Hao Chou; Robert D Goldman
Journal:  J Cell Sci       Date:  2004-02-03       Impact factor: 5.285

Review 3.  Regulation of Bcl-2 proteins during anoikis and amorphosis.

Authors:  Stuart S Martin; Kristiina Vuori
Journal:  Biochim Biophys Acta       Date:  2004-07-05

Review 4.  Cancer metastasis: building a framework.

Authors:  Gaorav P Gupta; Joan Massagué
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

Review 5.  Tensegrity II. How structural networks influence cellular information processing networks.

Authors:  Donald E Ingber
Journal:  J Cell Sci       Date:  2003-04-15       Impact factor: 5.285

6.  Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis.

Authors:  A Mialhe; L Lafanechère; I Treilleux; N Peloux; C Dumontet; A Brémond; M H Panh; R Payan; J Wehland; R L Margolis; D Job
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

7.  Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.

Authors:  Balaji Krishnamachary; Shannon Berg-Dixon; Brian Kelly; Faton Agani; David Feldser; Gloria Ferreira; Narayan Iyer; Jessica LaRusch; Brian Pak; Panthea Taghavi; Gregg L Semenza
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

Review 8.  Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis.

Authors:  Josef Gotzmann; Mario Mikula; Andreas Eger; Rolf Schulte-Hermann; Roland Foisner; Hartmut Beug; Wolfgang Mikulits
Journal:  Mutat Res       Date:  2004-01       Impact factor: 2.433

9.  A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth.

Authors:  Stuart S Martin; Alan G Ridgeway; Jan Pinkas; Yu Lu; Mauricio J Reginato; Eugene Y Koh; Montserrat Michelman; George Q Daley; Joan S Brugge; Philip Leder
Journal:  Oncogene       Date:  2004-06-03       Impact factor: 9.867

10.  Association of Vimentin overexpression and hepatocellular carcinoma metastasis.

Authors:  Liang Hu; Sze Hang Lau; Chi-Hung Tzang; Jian-Ming Wen; Weisheng Wang; Dan Xie; Minghui Huang; Yi Wang; Meng-Chao Wu; Jie-Fu Huang; Wei-Fen Zeng; Jonathan S T Sham; Mengsu Yang; Xin-Yuan Guan
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

View more
  63 in total

Review 1.  Microtentacles tip the balance of cytoskeletal forces in circulating tumor cells.

Authors:  Michael A Matrone; Rebecca A Whipple; Eric M Balzer; Stuart S Martin
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement.

Authors:  Rebecca A Whipple; Michael A Matrone; Edward H Cho; Eric M Balzer; Michele I Vitolo; Jennifer R Yoon; Olga B Ioffe; Kimberly C Tuttle; Jing Yang; Stuart S Martin
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

3.  STAT3-stathmin interactions control microtubule dynamics in migrating T-cells.

Authors:  Navin K Verma; Jennifer Dourlat; Anthony M Davies; Aideen Long; Wang-Qing Liu; Christiane Garbay; Dermot Kelleher; Yuri Volkov
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

4.  Detyrosinated microtubules buckle and bear load in contracting cardiomyocytes.

Authors:  Patrick Robison; Matthew A Caporizzo; Hossein Ahmadzadeh; Alexey I Bogush; Christina Yingxian Chen; Kenneth B Margulies; Vivek B Shenoy; Benjamin L Prosser
Journal:  Science       Date:  2016-04-22       Impact factor: 47.728

Review 5.  Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

6.  Filamin A is required for vimentin-mediated cell adhesion and spreading.

Authors:  Hugh Kim; Fumihiko Nakamura; Wilson Lee; Yulia Shifrin; Pamela Arora; Christopher A McCulloch
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-23       Impact factor: 4.249

7.  Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.

Authors:  Joomin Lee; Eun-Ryeong Hahm; Adam I Marcus; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2013-11-30       Impact factor: 4.784

8.  Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation.

Authors:  David G Meckes; Nathan F Menaker; Nancy Raab-Traub
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  Partial thermal imidization of polyelectrolyte multilayer cell tethering surfaces (TetherChip) enables efficient cell capture and microtentacle fixation for circulating tumor cell analysis.

Authors:  Julia A Ju; Cornell J Lee; Keyata N Thompson; Eleanor C Ory; Rachel M Lee; Trevor J Mathias; Stephen J P Pratt; Michele I Vitolo; Christopher M Jewell; Stuart S Martin
Journal:  Lab Chip       Date:  2020-08-03       Impact factor: 6.799

10.  Increased phosphorylation of vimentin in noninfiltrative meningiomas.

Authors:  Ali Bouamrani; Claire Ramus; Emmanuel Gay; Laurent Pelletier; Myriam Cubizolles; Sabine Brugière; Didier Wion; François Berger; Jean-Paul Issartel
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.